Bone-marrow lymphocytes in acute lymphoid leukaemia: effect of therapeutic regimes.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D001853:Bone Marrow; D001854:Bone Marrow Cells; D001856:Bone Marrow Examination; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000473:pathology*; D008214:Lymphocytes; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012075:Remission, Spontaneous; D012189:Retrospective Studies; D013223:Statistics as Topic; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014750:Vincristine; D003520:Cyclophosphamide; D001215:Asparaginase; D011241:Prednisone; D008727:Methotrexate